Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Mar 19.
Published in final edited form as: Inorg Chem. 2012 Mar 1;51(6):3625–3632. doi: 10.1021/ic2025236

Reaction of Metal Binding Ligands with the Zinc Proteome: Zinc Sensors and TPEN

Jeffrey W Meeusen 1,2, Andrew Nowakowski 1, David H Petering 1,*
PMCID: PMC3564517  NIHMSID: NIHMS361013  PMID: 22380934

Abstract

The commonly used Zn2+ sensors, TSQ and Zinquin, have been shown to image Zn-proteins as a result of the formation for sensor-Zn-protein ternary adducts not Zn(TSQ)2 or Zn(Zinquin)2 complexes. The powerful, cell permeant chelating agent TPEN is also used in conjunction with these and other Zn2+ sensors to validate that the observed fluorescence enhancement seen with the sensors depends on intracellular interaction with Zn2+. We demonstrated that the kinetics of reaction of TPEN with cells pretreated with TSQ or Zinquin was not consistent with its reaction with Zn(TSQ)2 or Zn(Zinquin)2. Instead, TPEN and other chelating agents extract between 25–35% of the Zn2+ bound to the proteome, including Zn2+ from Zn-metallothionein, and, thereby, quench some but not all of the sensor-Zn-protein fluorescence. Another mechanism in which TPEN exchanges with TSQ or Zinquin to form TP EN-Zn-protein adducts found support in the reactions of TPEN with Zinquin-Zn-alcohol dehydrogenase. TPEN also removed one of the two Zn2+ ions per monomer from Zn-alcohol dehydrogenase and Zn-alkaline phosphatase, consistent with its ligand substitution reactivity with the Zn-proteome.

Introduction

Zinc is an essential trace metal thought to be a co-factor in an estimated 2800 mammalian proteins.1,2 In addition to its well described catalytic and structural roles, transient Zn2+ trafficking among protein binding sites may contribute to changes in cellular state.3 For example, as much as 10% of the zinc found in the brain is loosely bound and localized to the hippocampus, an area of the brain thought to involve memory.4,5 This transient pool of zinc is thought to be a chemical messenger in neural synapses.

Nutrient zinc insufficiency and deficiency readily occur in human populations.6,7 In experimental animals, they cause a host of adverse physiological effects that presumably result from perturbations of intracellular Zn2+ distribution.811 The molecular origin of such effects remains poorly understood.12,13

TPEN, 2,2,2',2'-tetrapyridyl-ethylene diamine, is a high affinity metal ion chelator that in its deprotonated form is neutral and readily crosses cell membranes.14,15 Its complement of pyridyl and amine nitrogen ligands bind Zn2+ with an apparent log stability constant of 15.6 M−1 at pH 7.2.16 These properties support its use in two primary types of experiments with cells in culture. In one, TPEN is added to cells to chelate labile or loosely bound, Zn2+ involved in trafficking, in order to render them functionally Zn2+ deficient for the purpose of understanding the responses of cells to nutrient Zn2+ deficiency.1719

Zn2+TRANSIT+TPENZn-TPEN (1)

In the other, after incubation with a Zn-fluorescent sensor, TPEN is added to cells, undergoes reaction 2, and, thereby, validates that the fluorescence observed is due to the actual formation of Zn-sensor complexes:14,20

Zn-Sensor+TPENZn-TPEN+Sensor (2)

The current experiments revisit these types of experiments for two interrelated reasons. First, TPEN is an exceptionally strong, promiscuous metal ion chelator.1619 Instead of binding only free or loosely bound Zn2+ that enters the cell, mimicking nutrient Zn2+ deficiency, it might undergo ligand substitution with Zn-proteins and, likewise, disturb the normal distribution of other metals such as Fe and Cu:

Zn-Protein+TPENZn-TPEN+Apo-protein (3)

Second, it has been demonstrated recently that the commonly used Zn2+ sensors TSQ and Zinquin react primarily with Zn-proteins to form TSQ-Zn-protein ternary complexes not with intracellular Zn2+ to produce Zn(TSQ)2.21,22 TPEN quenches much of the fluorescence emission that results the reaction of these Zn2+ sensors with cells. Previously, it was assumed that the reaction of TPEN with Zn(TSQ)2 or Zn(ZQ)2 accounted for the observed fluorescence quenching. With the new understanding of the mechanism of fluorescence enhancement in cells exposed to these sensors, the underlying chemistry of TPEN dependent quenching reaction needs to be reconsidered in an investigation of possible reactions of TPEN with sensor-Zn-proteins. In one hypothetical reaction, TPEN competes for Zn2+ bound in the ternary complex or competes with TSQ or ZQ for binding to Zn-proteins:

Sensor-Zn-protein+TPENZn-TPEN+apo-protein+Sensor (4)

In the other, TPEN exchanges with the sensor in the ternary adduct:

Sensor-Zn-protein+TPENTPEN-Zn-protein+Sensor (5)

The impetus to undertake this study stems in part from the lack of recognition that TPEN with its powerful metal ion chelating properties might well react with Zn-proteins as well as loosely bound Zn2+.14,1620,2326 The present experiments provide support for hypotheses that reactions 3–5 operate in cells.

Methods

Cell culture

LLC-PK1 cells were purchased from the American Tissue Culture Company. Medium 199 with HEPES growth media was supplemented with 50,000 units/L Penicillin G, 50 mg/L streptomycin and 4% fetal calf serum. Flasks were incubated under 5% CO2 at 37° C and the medium was changed every 48 hours. Cultures were subdivided by trypsin/EDTA treatment every 5–7 days.

Reactions and spectrofluorimetry of cells or cell lysates exposed to TSQ or ZQ followed by TPEN

Exposures to TPEN, ZQ, TSQ, pyrithione, or ZnCl2 were conducted at concentrations that did not affect viability as measured by the MTT assay.27 Cells were grown in 35 mm culture plates and rinsed three times with Dulbecco's phosphate buffered saline (DPBS) prior to being stained for with TSQ or ZQ. After staining, cells were again rinsed three times and finally suspended in DPBS. Lysates were prepared from TSQ/ZQ stained cells by sonicating cells in 50 mM TRIS-Cl, pH 7.4, and clarifying by centrifugation at 47,000 or 100,000 g. Cell suspensions or supernatants in the above buffer were added to a fluorescence cuvette. Their emission spectra were recorded between 400–600 nm with a Hitachi F4500 spectrofluorometer using an excitation wavelength of 360 nm and a temperature of 25° C. All experiments with cells or supernatants were conducted under these conditions.

Sephadex G-75 chromatography and isolation of Zn-proteome, and metal analysis

Sephadex G-75 size exclusion chromatography beads were purchased from Sigma. Beads were initially hydrated in 20 mM Tris-Cl pH 7.4. Columns were 0.75 mm × 90 cm, sample was eluted by gravity reservoir, and 20 drop fractions were collected. The void volume was ~8mL and fractions 10–20 contained molecules larger than 10 kDa, referred to as the proteome. A subset of these proteins would be the Zn-proteome. Fractions 20–30 included molecules ~10 kDa in size, and fractions 30–40 were comprised of the low molecular weight species. The 10 kDa species Zn-containing species was identified as MT by amino acid analysis.21

The metal content of each fraction was measured by flame atomic absorption spectrophotometry (AAS). The GBC model 904AA instrument atomized samples with an acetylene torch using an 80:20 mix of compressed air and acetylene. Measurements were obtained with a Zn element lamp and a deuterium background lamp. Data acquisition was performed in running mean mode and calibrated prior to each run using standards of 7.7, 15.4, and 30.8 μM Zn2+ that correspond to 0.5, 1.0, and 2.0 μg/mL Zn2+.

Reactions of TPEN with model Zn-proteins

Bovine erythrocyte alkaline phosphatase (AP) was obtained from Sigma. This protein, which binds 2 Zn2+ per monomer was prepared to a concentration of 25 mg/mL by dissolving in degassed 50 mM HEPES and 0.1 M KNO3 buffer, pH 7.2. Yeast alcohol dehydrogenase was purchased from Worthington Biochemical Corporation. It contains 2 Zn2+ per monomer. The protein was prepared by dissolving the lyophilized powder in degassed 20 mM Tris-Cl buffer, pH 7.4 to a final concentration of 10 mg/mL. Fractions were assayed for Zn2+ by AAS and protein by the Lowry Assay (BIO-Rad DC Protein Kit).28 Proteins were mixed with TSQ or ZQ at indicated concentrations prior to addition of TPEN in the above buffers at 25° C.

Activity Assays for Zn2-ADH and Zn2-AP

Zn2-ADH or Zn-ADH (0.05–01 μM) was reacted with 0, 2.5, 5, 10, 25, 50, 75 and 100 mM ethanol in the presence of 15 mM NAD in 10 mM Na2P2O7 buffer pH 8.8 at 25° C. The conversion of NAD to NADH was monitored at 340 nm for 30 seconds and an initial rate was measured as absorbance/min. Zn2-AP or Zn-AP (0.075 μM) was reacted with 0, 10, 25, 50, 100, 250, 500, 1000, and 2000 μM 4-nitrophenyl phosphate in 50 mM HEPES buffer pH 8.2. The conversion of 4-nitrophenyl phosphate to 4-nitrophenol was monitored at 405 nm for 30 seconds and an initial rate was determined as absorbance/min.

Kinetic analysis of reactions

Formation of Zn-TPEN upon ligand substitution reaction of pseudo-first order excesses of TPEN with Zn(TSQ)2 or Zn(ZQ)2 was monitored by loss of fluorescence or change in absorbance, respectively. A plot of ln[Zn(sensor)2] vs.time in seconds yielded a linear curve. The slope of the line was the best-fit linear regression and was called kOBSERVED.

Results

Toxicity of TPEN and Zn-TPEN

LLC-PK1 cells were completely viable after exposure to 100 μM TPEN for one hour. However, 24 hour exposure reduced cell viability to 30% (Figure 1). The effect was ameliorated by addition of equimolar ZnCl2 to the TPEN reagent. The increased survival of cells exposed to Zn-TPEN compared to cells exposed to TPEN alone, suggested that at least some of the toxicity of TPEN was derived from its metal chelating properties.

Figure 1.

Figure 1

Cellular viability following 18 h exposure to TPEN with and without Zn2+.

TPEN quenching of TSQ dependent cellular fluorescence-comparison with Zn(TSQ)2

LLC-PK1 cells stained with TSQ displayed a fluorescence λmax at 470 nm, indicative of the formation of TSQ-Zn-protein adducts.21 Subsequent incubation of a cell suspension containing 5 μM Zn2+ with 100 μM TPEN resulted in a 90% loss of fluorescence signal in seven minutes that followed first order kinetics with a kobs of 2.7 × 10−3s−1 (Figure 2A). The λmax of the residual fluorescence in the TPEN treated cells remained at 470 nm.

Figure 2.

Figure 2

Time dependent loss of fluoresence following incubation with TPEN. (A) Zn2+ (5μM) from ZnCl2 (50 mM Tris-Cl, pH 7.4), supernatant (50 mM Tris-Cl, pH 7.4), or cells (DPBS) was reacted first with 10μM TSQ to form fluorescent products and then with 100 μM TPEN at 25° C. (B) Pseudo-first order rate constants for the reaction of Zn(TSQ)2 (5 μM) with TPEN were plotted vs [TPEN] to obtain rate constants for the reaction.

In a related experiment, cell supernatant containing 5 μM Zn2+ was mixed with 10 μM TSQ. The resulting fluorescence emission spectrum exhibited a λmax at 470 nm, consistent with the formation of TSQ-Zn-proteins. Addition of 100 μM TPEN resulted in a first order decay in fluorescence with a kobs of 2.1 × 10−3 s−1 (Figure 2A). Using 100 μM TPEN, cells and supernatant containing the same concentration of total Zn2+ and pretreated with TSQ reacted with similar pseudo-first order kinetics.

For comparison, we examined the reaction of 100 μM TPEN with 5 μM Zn(TSQ)2, the Zn2+ species that had previously been thought to account for TSQ dependent cellular fluorescence. This reaction reached 90% completion in less than 100 seconds and was characterized by a pseudo-first order rate constant of 2.5 × 10−2 s−1 (Figure 2A). According to these results, the induced loss of fluorescence caused by TPEN was fivefold faster with Zn(TSQ)2 than with TSQ stained cells or supernatant exposed to TSQ. Each of these reactions was carried out under pseudo-first order conditions for TPEN (100 μM) and the same concentration of Zn2+. Because TSQ-incubated cells and isolated cell supernatant reacted at similar rates with TPEN, it did not appear that diffusion of TPEN into cells was a rate-limiting event in this process. Thus, it was concluded that reaction of TPEN with intracellular Zn(TSQ)2 did not account for the cellular reaction that caused quenching of cellular fluorescence.

Characterizing the reaction of TPEN with Zn(TSQ)2 further, a series of pseudo-first order excess concentrations of TPEN was reacted with 2.5 μM Zn(TSQ)2 and the formation of Zn-TPEN monitored by the loss of fluorescence. Plotting the kOBSERVED for the rate of Zn(TSQ)2 decay against the concentration of TPEN revealed a linear relationship with a slope of 99 s−1 M−1 representing the second order rate constant (k2) for part of the reaction and a non-zero intercept of 2.7×10−3 s−1 (Figure 2B). The second order part of the rate equation is taken to represent the direct bimolecular reaction of TPEN with Zn(TSQ)2. The first order, TPEN-independent process, is hypothesized to involve rate limiting dissociation of a bulky quinolinesulfonamide moiety from the Zn2+ ion prior to rapid reaction of the remaining Zn-TSQ complex with TPEN.

Quenching of TSQ dependent cellular fluorescence by TPEN in the presence of extra Zn2+

Another common tool in experiments about Zn2+ trafficking is the use of the ionophore pyrithione (PYR), which forms hydrophobic Zn(PYR)2 complexes, to shuttle Zn2+ rapidly into cells. Incubation of 106 cells for 10 min with 3 μM PYR in the presence of 30 μM ZnCl2 resulted in a large increase in the fluorescence signal of intracellular TSQ. The signal increase was accompanied by a shift in λmax from 470 nm to 490 nm, consistent with the formation of Zn(TSQ)2 through the reaction of TSQ with Zn(PYR)2 (Figure 3).21 Addition of 100 μM TPEN reduced the fluorescence signal by nearly half within the time of mixing and then by about 50% again within two minutes. During this period, the λmax of the remaining signal moved toward 470 nm. Evidently, the rapid reaction represented the interaction of TPEN with Zn(TSQ)2. The remaining fluorescence (77%) declined slower. The initial, swift reaction involved TPEN and intracellular Zn(TSQ)2. Its rapidity verified that the flux of TPEN into the cells was, itself, a quick process that was not significantly rate limiting for the overall reaction. The slower decay process resulted from the quenching of the fluorescence of the original TSQ-Zn-protein adducts. This experiment, in particular, emphasized that the native fluorescent species involving TSQ is not Zn(TSQ)2, as neither its kinetics of reaction with TPEN nor its fluorescence emission spectrum matched results of the reaction of TPEN with native cells or cell supernatant.

Figure 3.

Figure 3

Fluorescence emission spectra of LLC-PK1 cells incubated with 30μM TSQ (blue) followed by addition of 30μM ZnCl2 and 3μM PYR (green), and then 100 μM TPEN (yellow, orange, red).

TPEN quenching of Zn2+ dependent ZQ fluorescence in LLC-PK1 cells and Zn-proteome

Zinquin is a Zn2+ sensor closely related to TSQ.22 To investigate the generality of the results with TSQ, the capacity of TPEN to quench the fluorescence of ZQ was examined in LLC-PK1 cells (approximately 5 μM total Zn2+) pretreated with 10 μM ZQEE, the esterified sensor that rapidly accumulates in cells. Upon cellular uptake, ZQEE was assumed to hydrolyze to ZQACID, which, in turn, reacted to generate a Zn2+-based fluorescence emission spectrum centered at 470 nm. As with TSQ, this spectrum is characteristic of the presence of ZQ-Zn-protein adduct species.22 All of the fluorescence was associated with the proteome fraction consistent with the production of ZQACID-Zn-protein adducts.22 When these cells were exposed to TPEN, a multi-phasic reaction took place in which about 70% of the fluorescence was quenched in the major first order reaction (Figure 4A). This result was compared to the reactions of 5 μM of isolated Zn-proteome with 10 μM ZQEE or ZQACID followed by quenching with 100 μM TPEN. The quenching of fluorescence of the ZQACID-exposed proteome with TPEN occurred with a qualitatively similar kinetic profile as seen in the intact cells, although the major step involving about 70% of the fluorescence occurred somewhat faster than in cells. ZQEE reacted more slowly. These results supported the hypothesis that TPEN was rapidly accumulated in cells and then reacted with the ZQACID-Zn-proteome as seen in vitro.

Figure 4.

Figure 4

Kinetics of quenching of Zinquin complexes by TPEN. (A) LLC-PK1 cells (5×106, approximately 5 μM total Zn2+) were exposed to 10 μM ZQEE (◇) for 15 minutes before fluorescence was quenched with 100 μM TPEN. Result was compared withuenching of fluorecence of ZQACID-Zn-proteome (black) and ZQEE-Zn-proteome (gray) with 100 μM TPEN. (B) Fluorescence decay after adding 100 μM TPEN to 5 μM Zn(ZQACID)2 and 5 μM Zn(ZQEE)2. Inset: linear regression of kobserved vs. [TPEN] for the reaction of 5 μM Zn(ZQEE)2 with TPEN (R2 = 0.99).

Reaction of TPEN with, Zn(ZQEE)2, and Zn(ZQACID)2

As models for the intracellular reactions of TPEN with ZQ-based complexes, the reactivity of TPEN with Zn(ZQEE)2 and Zn(ZQACID)2 was determined. Like Zn(TSQ)2, Zn(ZQACID)2 underwent rapid reaction with TPEN (Figure 4B). However, this reaction was zero order in TPEN and was characterized by a first order rate constant of 4.8×10−2 s−1. Unexpectedly, the reaction of Zn(ZQEE)2 with TPEN proceeded at a much slower rate (Figure 4B). Moreover, it occurred with second order kinetics, first order in both Zn(ZQEE)2 and TPEN (k = 1.82 M−1 s−1) with a non-zero y-intercept of 3.0 × 10−4 s−1.

The pseudo-first order rates of reaction of TPEN with Zn(TSQ)2 and Zn(ZQ)2 species were either much faster or slower than the observed reactions in cells, consistent with the idea that ZQ-Zn-protein species not Zn2+-sensor complexes are predominantly present in cells and undergo reaction with TPEN. Moreover, the relatively fast reaction of TPEN with ZQEE-treated cells in comparison with its reaction with ZQEE-Zn-proteome supported the conclusion that ZQEE was rapidly hydrolyzed to ZQACID once in cells. Finally, the difference in kinetic behavior of Zn(ZQ)2 species with TPEN was attributed to a much faster dissociation rate of ZQACID from Zn(ZQACID)2 than ZQEE from Zn(ZQEE)2, due to the electrostatic repulsion between the two negatively charged ZQACID ligands.

Reaction of TPEN with cellular proteomic Zn2+

Under standard culture conditions, LLC-PK1 cells contained 16 ± 4.2 nmol Zn2+/107 cells. Incubation of these cells with 25 μM TPEN for 30 minutes prior to isolation of cell supernatant did not significantly alter the total Zn2+ recovered (Table 1). Quantifying the distribution of supernatant Zn2+ after Sephadex G-75 chromatography revealed that the proteomic Zn2+ band retained 90–100% of its total Zn2+. The MT fraction was reduced by 60% while the low-molecular weight Zn2+ increased by 40%, indicative of the formation of Zn-TPEN. Increasing the concentration of TPEN to 100 μM, a concentration commonly employed in cellular experiments, reduced proteomic Zn2+ by 30 %.29,30 This reduction was accompanied by a 225 % increase in low molecular weight Zn2+ thought to be Zn-TPEN. The small amount of Zn7-MT (3.8 nmol/107 cells) typically present in LLC-PK1 cells was substantially reduced.

Table 1.

Intracellular distribution of Zn2+ (nmol/107 cells) following TPEN exposure.a

Cellular Fraction Zn2+ No Treatmentb Zn2+ 25 μM TPENc Zn2+ 100 μM TPENb
Proteome 9.7 ± 0.49 8.8 6.8 ± 2.4
Metallothionein 3.8 ± 0.19 2.3 2.2 ± 0.21
Low molecular weight 2.0 ± 0.10 2.9 4.5 ± 2.8
Total 15 ± 0.78 14.0 14 ± 1.5
a

Conditions: Cells were treated for 30 minutes with the given concentration of TPEN prior to harvesting and fractionation of the supernatant.

b

Average ± standard deviation (n = 3)

c

Single experiment at 25 μM TPEN

Reaction of TPEN and other ligands with Zn-proteins

Reactions 4 and 5 summarize how TPEN might quench the fluorescence of ZQACID-Zn-proteins. The first of these involves successful competition for proteomic Zn2+ by TPEN. A published experiment showed that a series of ligands differing in conditional stability constant for Zn2+ at pH 7 between 15.6 and 8.0 removes 20–30% of the Zn2+ from isolated Zn-proteome.31 In the present experiment, Zn-proteome from LLC-PK1 cells was reacted with a ten-fold excess of competing ligand (100 μM) for 30 min and the extent to ligand substitution transfer of Zn2+ from the proteome to the ligand determined by Sephadex G-75 chromatography. Using TPEN, EDTA, TREN, EGTA, and NTA as ligands spanning a 108 range in conditional stability constant, we observed that each sequestered about 30% of the proteomic Zn2+, suggestive that all of them might be reacting with the same set of Zn-proteins (Table 2). The reacted proteomes were isolated again by Sephadex G-75 chromatography and then tested for reactivity with Zinquin. In each reaction, less fluorescence was observed than been detected when the native proteome was probed with Zinquin.

Table 2.

Reactions of the LLC-PK1 Zn-proteome with chelating agents and modified Zn-proteome with Zinquina

Competitive Ligand Log Kb % Zn2+ Chelationc % Decrease in ZQ Fluorescencec
NTA 10.532 25±3 30±14
EGTA 8.833 25±3 51±23
TREN 14.432 26±2 43±7
EDTA 13.634 30±5 75±9
TPEN 15.416 35±2 77±3
a

Reaction conditions: Zn-proteome (10 μM Zn2+), treated for 30 min with 100 μM chelator in 20 mM Tris-Cl pH 7.4 buffer at 25° C.

b

(conditional stability constant, pH 7)

c

Average ± standard deviation, n=3

The extent of suppressed fluorescence was qualitatively and inversely related to the stability constant as seen in Table 2. For example, initial reaction of TPEN with the Zn-proteome resulted in 75% loss in fluorescence, whereas NTA depressed fluorescence only 35%. These findings implied that these ligands react with different subsets of the Zn-proteome that, in turn, are differentially involved in binding ZQACID. Moreover, the results with TPEN indicated that up to 75% of the quenching of cellular ZQ fluorescence described above might be attributable to chelation of Zn2+ bound in ternary, ZQ-Zn-protein adducts. In addition, residual TPEN, itself, may remain bound to Zn-proteins as TPEN-containing adducts. According to this picture, the residual fluorescence that remained (25%) represented ZQ-Zn-protein adducts that were able to form because TPEN had not sequestered Zn2+ from these Zn-proteins. If high concentrations of TPEN were present as in cells, the residual fluorescence might also be quenched as ZQ was replaced competitively by TPEN resulting in the formation of TPEN-Zn-proteins.

TPEN reaction with ZQ-Zn-ADH and ZQ-Zn-AP

The reactions of TPEN with mixtures of ZQ and Zn2-ADH or Zn2-AP were investigated as models for the behavior of TPEN with ZQ-treated Zn-proteome. Previously, it was demonstrated that ZQACID readily chelated 50% of the Zn2+ in each protein, assumed to represent one of the two Zn2+ ions in each protein monomer, as Zn(ZQACID))2.22 The fluorophore also formed a fluorescent adduct with the other Zn2+ in Zn-ADH (ZQACID-Zn-ADH) but did not react with the second site in Zn-AP.22

3ZQACID+ZnA,ZnB-ADHZQACID-ZnA-ADH+ZnB(ZQACID)2 (6)
2ZQACID+ZnA,ZnB-APZnA-AP+ZnB(ZQACID)2 (7)

The reaction of 100 μM TPEN with a mixture of 5 μM Zn2ADH and 20 μM ZQACID quenched the fluorescence of Zn(ZQACID)2 as well as ZQACID-Zn-ADH, but did not extract the second Zn2+ ion from ADH according to Sephadex G-75 analysis of the product mixture (Figures 5A and B). Moreover, reactions of 5 μM Zn2-Proteins with 100 μM TPEN removed only one Zn2+ (Figure 5D and E). This implied that TPEN replaced ZQACID in a ternary complex with ZnA-ADH:

ZQACID-ZnA-ADH+TPENTPEN-ZnA-ADH+ZQACID (8)

As expected, addition of TPEN to the reaction mixture of Zn2-AP and ZQACID also destroyed the resident fluorescence from Zn(ZQACID)2 but like ZQACID, did not remove ZnA2+ from ZnA-AP (Figures 5A and C). Control reactions of TPEN with Zn2-ADH and Zn2-AP revealed that TPEN was reactive with only one of the two Zn2+ ions in each of these proteins.

Figure 5.

Figure 5

Reactions of TPEN with reaction mixtures of ZQACID and Zn2-ADH or Zn2-AP. (A) Decay kinetics of 5 μM ZQACID-Zn2-ADH (gray) and ZQACID-Zn2-AP (black) with 100 μM TPEN. Reactions mixtures of ZQACID-Zn2-ADH (B) and ZQACID-Zn2-AP (C) with TPEN were then chromatographed using Sephadex G-50 gel filtration. 5 μM Zn2-ADH (D) and Zn2-AP (E) were reacted with 100 μM TPEN for 30 minutes followed by separation by Sephadex G-50 gel filtration.

Activity assays were performed on both ZnA-AP and ZnA-ADH after chelation of ZnB. In each case, the activities were diminished (27% for ZnA-ADH and 19% for ZnA-AP) compared to those of the holoenyzmes. Since the activities were only modestly diminished, the results were consistent with the hypothesis that the structural Zn2+, identified as ZnB2+, not the catalytic Zn2+ was removed in these reactions.

These reactions displayed the range of activity of TPEN in quenching ZQACID associated fluorescence. TPEN can sequester Zn2+ from protein binding sites and, thereby, erase fluorescence due to ZQACID-Zn-protein adduct formation. It may accomplish the same end by substituting for ZQACID in such ternary adducts. It can also extract Zn2+ from sites that do not react with ZQACID.

Discussion

It is commonly assumed that Zn2+ fluorescent sensors image Zn2+ that is thermodynamically and kinetically available for chelation under the prevailing conditions within the cell.35,36 Since there is little if any free, aquated Zn2+, it is assumed that the sensor, S, competes with Zn-complexes within the cell depending on their apparent stability constants for Zn2+, their concentrations, and the mechanistic opportunity for ligand substitution between them:37,38

Zn-complex+SZn-S+apo-complex (9)

Depending on changes in intracellular chemical conditions, various Zn2+ binding sites may be modified to alter their reactivity with the fluorescent sensor. For example, enhanced fluorescence of TSQ and other sensors after exposure of cells to nitric oxide has been interpreted as resulting from modification of sulfhydryl ligands in Zn-proteins such as metallothionein that released Zn2+ for reaction with the sensor.29,39

Recent studies have demonstrated that TSQ and Zinquin primarily image intracellular Zn-proteins in a variety of cell types.21,22 They do so by forming ternary fluorescent adducts with a subset of the Zn-proteome (e,g.):

TSQ+Zn-proteinTSQ-Zn-protein (10)

In studying the nature of the reaction of TSQ with cells, we followed the usual protocol: cells were incubated with TSQ and enhanced fluorescence emission was recorded.21 Then, exogenous Zn2+ was added to the cells in the form of the permeant complex, Zn(pyrithione)2 to show that a source of Zn2+ would cause further enhancement in fluorescence. Finally, TPEN, a powerful, cell permeant chelating agent for Zn2+, was supplied to quench the fluorescence and, thereby, confirm that the fluorescence emission was due to the formation of the Zn(TSQ)2 complex.16

Zn(TSQ)2+2TPEN2Zn-TPEN+2TSQ (11)

It was assumed that all of the fluorescence enhancement following addition of Zn(pyrithione)2 resulted from the formation of Zn(TSQ)2, which readily reacts with TPEN (Figures 2 and 3). With the emergence of the robust hypothesis that TSQ actually fluoresces due to the formation of TSQ-Zn-proteins, it became necessary to reconsider how TPEN quenches the fluorescence of such adducts.21 Reactions 4 and 5 describe the two alternatives that were explored. TPEN may compete with TSQ-Zn-protein for Zn2+, forming Zn-TPEN and depriving TSQ of its Zn-binding site. Or, TPEN might compete directly with TSQ for binding to the Zn-protein, excluding TSQ from the protein binding site for Zn2+.

Initially, the first explanation was investigated, starting with a survey of the toxicity of TPEN in LLC-PK1 cells. Upon incubation for 1 h with 100 μM TPEN, a concentration regularly used in Zn2+ sensor experiments, cells displayed no gross evidence of toxicity (Figure 1). However, over a period of 24 h, cells experienced a TPEN concentration dependent loss of viability. An obvious hypothesis to explain this result was that intracellular TPEN had extracted Zn2+ from key Zn-proteins or otherwise disrupted Zn2+ trafficking. Consistent with this view, substitution of Zn-TPEN for TPEN significantly ameliorated toxicity, presumably because Zn-TPEN did not have the capacity to compete for intracellular Zn2+. Nevertheless, the fact that Zn-TPEN, itself, displayed some toxicity implied that reactions other than Zn-chelation might come into play when cells were exposed to this molecule.

Fluorescence quenching by TPEN in cells previously incubated with either TSQ or ZQEE occurred at slower rates than comparable reactions of TPEN with Zn(TSQ)2 or Zn(ZQACID)2 observed in vitro and in cells with Zn(TSQ)2 (Figures 2 and 4). These results provided additional support for the conclusion that neither TSQ nor ZQ primarily imaged Zn2+.21,22 Instead, if sensor-Zn-protein adducts were formed, other modes of fluorescence quenching must be involved.

TPEN is a potent Zn2+ chelating agent and it would not be surprising if it effectively competed with intracellular pools of Zn2+ other than Zn(TSQ)2 or Zn(ZQACID)2 to form Zn-TPEN.16 Indeed, an earlier report demonstrated that multidentate ligands including TPEN that varied in log apparent stability constant for Zn2+ at pH 7 between 8 and 16 removed 20–30% of the total Zn2+ from isolated Zn-proteome.31 The present experiments conducted with LLC-PK1 cells confirm that TPEN undergoes extensive ligand substitution with members of the Zn-proteome including Zn-metallothionein (reaction 4) over time (Table 1). In the process, the reactivity of the residual Zn-proteome with ZQACID declined 75% in comparison with un-treated Zn-proteome. Thus, it is likely that TPEN quenches TSQ related fluorescence successfully by competing for protein associated Zn2+ which is bound to TSQ.

In the course of these experiments, we compared the properties of reaction of the Zn-proteome with TPEN and other Zn2+ chelators (Table 2). Under similar conditions, several multidentate ligands extracted similar fractions of proteomic Zn2+, suggestive of a common pool of Zn2 that is relatively available for ligand substitution reaction. But when the residual Zn-proteome was interrogated with ZQACID, strikingly different amounts of fluorescence enhancement were observed, ranging from 24% for EGTA to 85% for EDTA. The wide span of reactivity indicated that members of this set of ligands accessed different Zn-proteins in their reactions with the Zn-proteome. Considering the large span of Zn2+ stability constants and variety of structures of this group of chelating agents, these results signal that ligand substitution with proteome-bound Zn2+ is likely to be a common reaction when cells are treated with reagents that have even intermediate Zn2+ binding affinity.

TSQ and ZQ behaved differently than these chelating agents with the Zn-proteome. Neither TSQ nor ZQACID mobilized Zn2+ out of the LLC-PK1 proteome or the Zn-proteomes from a variety of other cell types.22 The overall log conditional stability constant of Zn(ZQACID)2 at pH 7 is 13, indicating that ZQACID should also compete effectively for proteomic Zn2+.40 Perhaps, there is a kinetic barrier to reaction that plays a role in its inactivity. We hypothesize that the rate limiting step in ligand substitution for the ligands we studied may be the replacement of the third or fourth metal binding group of the protein with a group from the competing ligand. For multidentate ligands with several intramolecular ligating groups, this is feasible. But with bidentate ligands, such as TSQ and ZQACID, less favorable intermolecular addition must take place and overall ligand substitution becomes difficult. In this circumstance, adduct formation is favored.

In the course of these experiments, we also surveyed the effects of TPEN on the intracellular distribution of other transition metals. Just as this powerful ligand removed Zn2+ from the proteome, so too, it competed for 20% of the proteomic Fe and significant fractions of proteomic and MT-bound Cu (data not shown). These results underscore that TPEN is a promiscuous chelating agent of transition metal ions in cells. Because it competed directly with the proteome for Zn2+, TPEN cannot be thought of as an innocent substitute for Zn-depleted extracellular medium in the induction of cellular Zn2+ deficiency, despite its frequent use for this purpose.1719 The fact that Zn-saturated TPEN displayed some toxicity emphasizes that this hexadentate ligand interacts in multiple ways with cells besides simply reacting with free Zn2+. This includes reaction with Fe and Cu pools and forming ternary complexes with Zn-proteins.

In vitro analysis of the reactions of TPEN with Zn2-ADH and Zn2-AP provides a model for two unique modes of TPEN perturbation of cellular Zn2+. That TPEN was able to remove one of the Zn2+ ions from either Zn2-ADH or Zn2-AP agreed with the Zn-proteomic findings that TPEN was capable of sequestering some but not all of the proteomic Zn2+ (Table 2). In addition, TPEN competed successfully with ZQACID-Zn-ADH to form what we hypothesize to be TPEN-Zn-ADH (Table 3 and Figure 6). Besides serving as a second mechanism that quenches the fluorescence that results from the formation of TSQ- or ZQ-Zn-proteins, this finding also opens the possibility that TPEN alters cell behavior, in part, by binding to Zn-proteins.

Table 3.

Reaction of TPEN with mixtures of ZQACID or ZQEE and Zn2-ADH or Zn2-AP

Reactiona ZnA ZnB
Zn2-ADH + ZQAcid Fluorescent Adduct (472 nm)b Chelation as Zn(ZQAcid)2 (492 nm)b
Zn2-ADH + ZQAcid + TPEN Fluorescence Quench of Adduct (slower phase, Fig. 5A; no loss of Zn2+)c Fluorescence Quench of Zn(ZQAcid)2 (faster phase-Fig. 5A)c
Zn2-ADH + ZQEE No chelation of Zn2+; fluorescent adduct, 471 nm2 --- ---
Zn2-ADH + ZQEE + TPEN Fluorescence Quench of Adduct (Fig. 1s)c Chelation as Zn-TPEN
Zn2-ADH + TPEN No chelation of Zn2+ d Chelation as Zn-TPEN
Zn2-AP + ZQAcid No Reaction Chelated as Zn(ZQAcid)2 (492 nm)b
Zn2-AP + ZQAcid + TPEN No chelation of Zn2+ Fluorescence Quench of Zn(ZQAcid)2 (fast, Fig. 5A)c
Zn2-AP + ZQEE No chelation of Zn2+; fluorescent adduct, 471 nm2 --- ---
Zn2-AP + ZQEE + TPEN Fluorescence Quench of Adduct (no loss of Zn2+, Fig. 1s)c Chelation as Zn-TPEN
Zn2-AP + TPEN No chelation of Zn2+ d Chelation as Zn-TPEN
a

Reaction conditions: [Zn2-ADH] or [Zn2-AP] = 5 μM; [ZQAcid] or [ZQEE] = 10 μM; [TPEN] = 100 μM in 20 mM Tris-Cl pH 7.4 buffer at 25° C.

b

λMAX of spectra; see Ref. 22

c

Qualitative rate

d

Enzyme activity retained

The present study demonstrates that the activity of TPEN in living cells is more complicated than commonly assumed. Not only is it expected to be reactive with loosely bound Zn2+ that might be involved in processes of Zn2+ trafficking; it also competes successfully for a significant percentage of proteome-bound Zn2+. Moreover, it can form adduct species with Zn-proteins. Thus, it is not an innocent by-stander in cells that serves as an experimental substitute for nutrient Zn2+ deficiency. The fact that TPEN can participate in both reactions 4 and 5 provides an explanation for its ability to quench the fluorescence of TSQ- and ZQ-Zn-protein adducts and further strengthens the hypothesis that such ternary complexes account for much of the observed fluorescence emission in cells exposed to these sensors.

Supplementary Material

1_si_001

Acknowledgements

Funding was made possible by the NIH grants GM-85114 and ES-04184. Initial funds were from the University of Wisconsin – Milwaukee Research Growth Initiative. Metal analyses were conducted with the aid of the Children's Environmental Health Sciences Core Center. We thank Susan Krezoski for her technical support.

Abbreviations

AAS

atomic absorption spectrophotometry

CA

bovine serum carbonic anhydrase

DPBS

Dulbecco's phosphate buffered saline

DTNB

5,5-dithiobis-2-nitrobenzoic acid

EDTA

ethylenediaminetetraacetate

EGTA

ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid

MT

metallothionein

MTT

3(4,5-dimethyl-2-thiazoyl)-2,5-diphenyl-2H-tetrazolium, bromide

4-NPA

p-nitrophenyl acetate

NTA

nitrilotriacetate

PYR

pyrithione

sensor

TSQ or ZQ

TREN

Tris(2-aminoethyl)amine

TSQ

6-methoxy-8-p-toluenesulfonamido-quinoline and Figure 1

TPEN

N,N,N'N'-tetrakis(−)[2-pyridylmethyl]-ethylenediamine

ZQACID Zinquin acid

(2-methyl-8-p-toluenesulfonamido-6-quinolyloxy)acetate)

ZQ

ZQACID or ZQEE

ZQEE Zinquin ethylacetate

ethyl[2-methyl-8-p-toluenesulfonamido-6-quinolyloxy]acetate)

References

  • (1).Andreini C, Banci L, Bertini I, Rosato A. J. Proteome Res. 2006;5:196–201. doi: 10.1021/pr050361j. [DOI] [PubMed] [Google Scholar]
  • (2).Andreini C, Banci L, Bertini I, Rosato A. J. Proteome Res. 2006;5:3173–8. doi: 10.1021/pr0603699. [DOI] [PubMed] [Google Scholar]
  • (3).Vallee BL, Auld DS. Faraday Discuss. 1992;93:47–65. doi: 10.1039/fd9929300047. [DOI] [PubMed] [Google Scholar]
  • (4).Budde T, Minta A, White JA, Kay AR. Neuroscience. 1997;79:347–58. doi: 10.1016/s0306-4522(96)00695-1. [DOI] [PubMed] [Google Scholar]
  • (5).Lu YM, Taverna FA, Tu R, Ackerley CA, Wang YT, Roder J. Synapse. 2000;38:187–97. doi: 10.1002/1098-2396(200011)38:2<187::AID-SYN10>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  • (6).Prasad AS. J Am Coll Nutr. 2009;3:257–65. doi: 10.1080/07315724.2009.10719780. [DOI] [PubMed] [Google Scholar]
  • (7).Cole CR, Lifshitz F. Pediatr Endocrinol Rev. 2008;4:889–96. [PubMed] [Google Scholar]
  • (8).Walsh CT, Sandstead HH, Prasad AS, Newberne PM, Fraker PJ. Environ. Health Perspect. 1994;102(Suppl 2):5–46. doi: 10.1289/ehp.941025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (9).Fraker PJ, King LE. Annu. Rev. Nutr. 2004;24:277–98. doi: 10.1146/annurev.nutr.24.012003.132454. [DOI] [PubMed] [Google Scholar]
  • (10).Fraker PJ. J. Nutr. 2005;135:359–62. doi: 10.1093/jn/135.3.359. [DOI] [PubMed] [Google Scholar]
  • (11).Fukada T, Kambe T. Metallomics. 2011;3:662–74. doi: 10.1039/c1mt00011j. [DOI] [PubMed] [Google Scholar]
  • (12).Daniel H, tom Dieck H. Biol. Chem. 2004;385:571–83. doi: 10.1515/BC.2004.071. [DOI] [PubMed] [Google Scholar]
  • (13).Ho E, Dukovcic S, Hobson B, Wong CP, Miller G, Hardin K, Traber MG, Tanguay RL. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2011 doi: 10.1016/j.cbpc.2011.05.002. Epub. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Zalewski PD, Forbes IJ, Betts WH. Biochem. J. 1993;296:403–8. doi: 10.1042/bj2960403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (15).Arslan P, Di Virgilio F, Beltrame M, Tsien RY, Pozzan T. J. Biol. Chem. 1985;260:2719–27. [PubMed] [Google Scholar]
  • (16).Anderegg G. Chim. Acta. 1977;60:123–140. [Google Scholar]
  • (17).Lu H, Pang W, Hu YD, Yang HP, Huang CY, Jiang YG. Nutr Neurosci. 2011;14:80–7. doi: 10.1179/1476830511Y.0000000004. [DOI] [PubMed] [Google Scholar]
  • (18).Shin JH, Jung HJ, An YJ, Cho YB, Cha SS, Roe JH. Proc. Natl. Acad. Sci. U S A. 2011;108:5045–50. doi: 10.1073/pnas.1017744108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (19).Bernhardt ML, Kim AM, O'Halloran TV, Woodruff TK. Biol Reprod. 2011;84:526–36. doi: 10.1095/biolreprod.110.086488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (20).Tang ZL, Wasserloos KJ, Liu X, Stitt MS, Reynolds IJ, Pitt BR, St. Croix CM. Mol. Cell. Biochem. 2002;234–235:211–7. [PubMed] [Google Scholar]
  • (21).Meeusen JW, Tomasiewicz H, Nowakowski A, Petering DH. Inorg. Chem. 2011;50:7563–7573. doi: 10.1021/ic200478q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (22).Nowakowski A, Meeusen JW, Petering DH. Inorg. Chem. 2011;50:10124–10133. doi: 10.1021/ic201076w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (23).Lee JY, Kim JS, Byun HR, Palmiter RD, Koh JY. Brain Res. 2011;1418:12–22. doi: 10.1016/j.brainres.2011.08.055. [DOI] [PubMed] [Google Scholar]
  • (24).Kruczek C, Görg B, Keitel V, Pirev E, Kröncke KD, Schliess F, Häussinger D. Glia. 2009;57:79–92. doi: 10.1002/glia.20737. [DOI] [PubMed] [Google Scholar]
  • (25).Devergnas S, Chimienti F, Naud N, Pennequin A, Coquerel Y, Chantegrel J, Favier A, Seve M. Biochem Pharmacol. 2004;68:699–709. doi: 10.1016/j.bcp.2004.05.024. [DOI] [PubMed] [Google Scholar]
  • (26).Sauer GR, Smith DM, Cahalane M, Wu LN, Wuthier RE. J Cell Biochem. 2003;88:954–69. doi: 10.1002/jcb.10446. [DOI] [PubMed] [Google Scholar]
  • (27).Hatok J, Babusikova E, Matakova T, Mistuna D, Dobrota D, Racay P. Clin. Exp. Med. 2009;9:1–7. doi: 10.1007/s10238-008-0011-3. [DOI] [PubMed] [Google Scholar]
  • (28).Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. J. Biol. Chem. 1951;193:265–75. [PubMed] [Google Scholar]
  • (29).St. Croix CM, Wasserloos KJ, Dineley KE, Reynolds IJ, Levitan ES, Pitt BR. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002;282:L185–92. doi: 10.1152/ajplung.00267.2001. [DOI] [PubMed] [Google Scholar]
  • (30).Zalewski PD, Fobes IJ, Seamark RF, Borlinghaus R.; Betts WH, Lincoln SF, Ward AD. Chem. & Biol. 1994;1:153–161. doi: 10.1016/1074-5521(94)90005-1. [DOI] [PubMed] [Google Scholar]
  • (31).Rana U, Kothinti R, Meeusen J, Tabatabai NM, Krezoski S, Petering DH. J. Inorg. Biochem. 2008;102:489–99. doi: 10.1016/j.jinorgbio.2007.10.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (32).Chiu Y, Canary JW. Inorg. Chem. 2003;42:5107–5116. doi: 10.1021/ic025855m. [DOI] [PubMed] [Google Scholar]
  • (33).Sillen LG, Martell AE. Stability Constants of Metal-Ion Complexes, Special Publication No. 25. The Chemical Society, Burlington House; London: 1971. pp. 733–735. [Google Scholar]
  • (34).Sillen LG, Martell AE. Stability Constants of Metal-Ion Complexes, Special Publication No. 25. The Chemical Society, Burlington House; London: 1971. pp. 623–632. [Google Scholar]
  • (35).Lim NC, Freake HC, Bruckner C. Chem. Eur. J. 2005;11:38–49. doi: 10.1002/chem.200400599. [DOI] [PubMed] [Google Scholar]
  • (36).Tomat E, Lippard SJ. Curr. Opin. Chem. Biol. 2010;14:225–230. doi: 10.1016/j.cbpa.2009.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (37).Krezel A, Maret WJ. Biol. Inorg. Chem. 2008;13:401–409. doi: 10.1007/s00775-007-0330-y. [DOI] [PubMed] [Google Scholar]
  • (38).Petering DH. Chemtracts: Inorg. Chem. 2004;17:569–580. [Google Scholar]
  • (39).Pearce LL, Wasserloos K, St. Croix CM, Gandley R, Levitan ES, Pitt BR. J. Nutr. 2000;130:1467S–70S. doi: 10.1093/jn/130.5.1467S. [DOI] [PubMed] [Google Scholar]
  • (40).Fahrni CJ, O'Halloran TV. J. Am. Chem. Soc. 1999;121:11448–11458. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES